FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3215869515> ?p ?o ?g. }

• W3215869515 endingPage "647" @default.
• W3215869515 startingPage "632" @default.
• W3215869515 abstract "Due to the employment of quadratic programming using soft constraints to implement dose volume constraints and the trial-and-error procedure needed to achieve a clinically acceptable plan, conventional dose volume constraints (upper limit) are not adequately effective in controlling small and isolated hot spots in the dose/linear energy transfer (LET) distribution. Such hot spots can lead to adverse events. In order to mitigate the risk of brain necrosis, one of the most clinically significant adverse events in patients receiving intensity-modulated proton therapy (IMPT) for base of skull (BOS) cancer, we propose per-voxel constraints to minimize hot spots in LET-guided robust optimization.Ten BOS cancer patients treated with IMPT were carefully selected by meeting one of the following conditions: (1) diagnosis of brain necrosis during follow-up; and (2) considered high risk for brain necrosis by not meeting dose constraints to the brain. An optimizing structure (BrainOPT) and an evaluating structure (BrainROI) that both contained the aforementioned hot dose regions in the brain were generated for optimization and evaluation, respectively. Two plans were generated for every patient: one using conventional dose-only robust optimization, the other using LET-guided robust optimization. The impact of LET was integrated into the optimization via a term of extra biological dose (xBD). A novel optimization tool of per-voxel constraints to control small and isolated hot spots in either the dose, LET, or combined (dose/LET) distribution was developed and used to minimize dose/LET hot spots of the selected structures. Indices from dose-volume histogram (DVH) and xBD dose-volume histogram (xBDVH) were used in the plan evaluation. A newly developed tool of the dose-LET-volume histogram (DLVH) was also adopted to illustrate the underlying mechanism. Wilcoxon signed-rank test was used for statistical comparison of the DVH and xBDVH indices between the conventional dose-only and the LET-guided robustly optimized plans.Per-voxel constraints effectively and efficiently minimized dose hot spots in both dose-only and LET-guided robust optimization and LET hot spots in LET-guided robust optimization. Compared to the conventional dose-only robust optimization, the LET-guided robust optimization could generate plans with statistically lower xBD hot spots in BrainROI (VxBD,50 Gy[RBE], p = 0.009; VxBD,60 Gy[RBE], p = 0.025; xBD1cc, p = 0.017; xBD2cc, p = 0.022) with comparable dose coverage, dose hot spots in the target, and dose hot spots in BrainROI. DLVH analysis indicated that LET-guided robust optimization could either reduce LET at the same dose level or redistribute high LET from high dose regions to low dose regions.Per-voxel constraint is a powerful tool to minimize dose/LET hot spots in IMPT. The LET-guided robustly optimized plans outperformed the conventional dose-only robustly optimized plans in terms of xBD hot spots control." @default.
• W3215869515 created "2021-12-06" @default.
• W3215869515 creator A5005492801 @default.
• W3215869515 creator A5023672968 @default.
• W3215869515 creator A5030089962 @default.
• W3215869515 creator A5038981517 @default.
• W3215869515 creator A5044868525 @default.
• W3215869515 creator A5062848479 @default.
• W3215869515 creator A5071037763 @default.
• W3215869515 creator A5079583428 @default.
• W3215869515 creator A5083170859 @default.
• W3215869515 creator A5085609688 @default.
• W3215869515 creator A5090691937 @default.
• W3215869515 creator A5091679738 @default.
• W3215869515 date "2021-12-10" @default.
• W3215869515 modified "2023-10-10" @default.
• W3215869515 title "Per‐voxel constraints to minimize hot spots in linear energy transfer‐guided robust optimization for base of skull head and neck cancer patients in IMPT" @default.
• W3215869515 cites W1965525170 @default.
• W3215869515 cites W1973920703 @default.
• W3215869515 cites W1976594584 @default.
• W3215869515 cites W1983273276 @default.
• W3215869515 cites W1986565583 @default.
• W3215869515 cites W1990381926 @default.
• W3215869515 cites W2011307344 @default.
• W3215869515 cites W2029775895 @default.
• W3215869515 cites W2040145532 @default.
• W3215869515 cites W2046829765 @default.
• W3215869515 cites W2055233491 @default.
• W3215869515 cites W2056035422 @default.
• W3215869515 cites W2060740081 @default.
• W3215869515 cites W2064712772 @default.
• W3215869515 cites W2066648318 @default.
• W3215869515 cites W2083770395 @default.
• W3215869515 cites W2085878148 @default.
• W3215869515 cites W2087937209 @default.
• W3215869515 cites W2094826639 @default.
• W3215869515 cites W2102192086 @default.
• W3215869515 cites W2103101993 @default.
• W3215869515 cites W2111442242 @default.
• W3215869515 cites W2112482103 @default.
• W3215869515 cites W2113922815 @default.
• W3215869515 cites W2115992979 @default.
• W3215869515 cites W2116345430 @default.
• W3215869515 cites W2117801253 @default.
• W3215869515 cites W2130599429 @default.
• W3215869515 cites W2143299496 @default.
• W3215869515 cites W2163329967 @default.
• W3215869515 cites W2293429046 @default.
• W3215869515 cites W2294774209 @default.
• W3215869515 cites W2300815560 @default.
• W3215869515 cites W2513819086 @default.
• W3215869515 cites W2531932775 @default.
• W3215869515 cites W2550452995 @default.
• W3215869515 cites W2563664032 @default.
• W3215869515 cites W2599198044 @default.
• W3215869515 cites W2727934984 @default.
• W3215869515 cites W2764174300 @default.
• W3215869515 cites W2769274260 @default.
• W3215869515 cites W2770163048 @default.
• W3215869515 cites W2770989174 @default.
• W3215869515 cites W2793623981 @default.
• W3215869515 cites W2800649452 @default.
• W3215869515 cites W2887409467 @default.
• W3215869515 cites W2894964113 @default.
• W3215869515 cites W2898026474 @default.
• W3215869515 cites W2898672813 @default.
• W3215869515 cites W2899297243 @default.
• W3215869515 cites W2904834068 @default.
• W3215869515 cites W2925044773 @default.
• W3215869515 cites W2940250016 @default.
• W3215869515 cites W2945552838 @default.
• W3215869515 cites W2964359941 @default.
• W3215869515 cites W2972593451 @default.
• W3215869515 cites W2991126798 @default.
• W3215869515 cites W2991165053 @default.
• W3215869515 cites W3002590463 @default.
• W3215869515 cites W3011832213 @default.
• W3215869515 cites W3013098905 @default.
• W3215869515 cites W3021747491 @default.
• W3215869515 cites W3026888739 @default.
• W3215869515 cites W3029696762 @default.
• W3215869515 cites W3034433855 @default.
• W3215869515 cites W3089320872 @default.
• W3215869515 cites W3130561878 @default.
• W3215869515 cites W3175701890 @default.
• W3215869515 cites W4242359199 @default.
• W3215869515 cites W4254677276 @default.
• W3215869515 cites W4382789439 @default.
• W3215869515 doi "https://doi.org/10.1002/mp.15384" @default.
• W3215869515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34843119" @default.
• W3215869515 hasPublicationYear "2021" @default.
• W3215869515 type Work @default.
• W3215869515 sameAs 3215869515 @default.
• W3215869515 citedByCount "11" @default.
• W3215869515 countsByYear W32158695152022 @default.
• W3215869515 countsByYear W32158695152023 @default.
• W3215869515 crossrefType "journal-article" @default.
• W3215869515 hasAuthorship W3215869515A5005492801 @default.

• next